{"id":"W4307889418","doi":"10.1093/ckj/sfac234","title":"A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease","year":2022,"lang":"en","type":"article","venue":"Clinical Kidney Journal","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"University of Chicago Medicine; Abbott Vascular; National Institutes of Health; Impulse Dynamics; Idorsia Pharmaceuticals; Bayer; Gilead Sciences; Servier; Vifor Pharma; Fresenius Medical Care North America; Astellas Pharma; Novo Nordisk; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Eli Lilly and Company; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Relypsa; University of Chicago; Akebia Therapeutics; European Commission; Steno Diabetes Center Copenhagen; Bayer HealthCare; Sanofi; Amgen","keywords":"Spironolactone; Medicine; Hyperkalemia; Discontinuation; Kidney disease; Internal medicine; Placebo; Mineralocorticoid receptor; Hazard ratio; Confidence interval; Cardiology; Urology; Endocrinology; Heart failure; Aldosterone; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009813497,0.0001642751,0.001123004,0.0008261238,0.0001231612,0.00001596874,0.00009613945,0.00006312317,0.0004126584],"category_scores_gemma":[0.001591422,0.0001340311,0.0002369278,0.0009185188,0.0001012542,0.00008483099,0.000131085,0.000763591,0.000003380798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000260352,"about_ca_system_score_gemma":0.001143934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003239515,"about_ca_topic_score_gemma":0.00007808895,"domain_scores_codex":[0.9974322,0.0003424347,0.001147484,0.0003519288,0.0004690006,0.0002570001],"domain_scores_gemma":[0.9975425,0.0002246486,0.0002567285,0.000240006,0.0002195092,0.001516592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2322316,0.0114374,0.4579257,0.0002703193,0.002779195,0.007115451,0.002827304,0.03965139,0.1861066,0.0004405098,0.01386197,0.04535256],"study_design_scores_gemma":[0.008940721,0.002207584,0.8992209,0.000250675,0.0005786605,0.00005982403,0.0003115337,0.08253415,0.0000467947,0.00008337698,0.005592566,0.0001732264],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872255,0.001002594,0.00005734582,0.01118076,0.00009121776,0.0002812821,0.00007816063,0.000007492228,0.00007560541],"genre_scores_gemma":[0.9939996,0.0003524151,0.0004448459,0.004850215,0.00006338254,0.000009142348,0.00009652852,0.00001388007,0.0001700048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4412952,"threshold_uncertainty_score":0.546563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05842416067394477,"score_gpt":0.3598073883686618,"score_spread":0.301383227694717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}